Jefferies downgraded Exact Sciences (EXAS) to Hold from Buy with a price target of $105, up from $90, citing the pending acquisition by Abbott (ABT). The firm thinks the takeover premium represents a win for Exact Sciences and does not expect another bidder to come over the top given precedent deal multiples.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences Downgraded to Hold Amid ABT Acquisition and Market Uncertainties
- Cathie Wood Loads Up on CoreWeave (CRWV), and Crypto Stocks; Trims Stakes in GitLab, AMD, and Other Tech Stocks
- Nasdaq, IonQ, Opko, Exact, Palo Alto: Trending by Analysts
- Cathie Wood Buys Nvidia, ACHR and Crypto Stocks, Offloads AMD, EXAS
- Exact Sciences downgraded to Hold from Buy at Craig-Hallum